Results 81 to 90 of about 1,025,401 (190)

Impact of Excluding Anti‐HLA‐C and ‐DP Antibodies From the Allocation System on Kidney Transplant Access

HLA, Volume 108, Issue 1, July 2026.
ABSTRACT Given the risk of antibody‐mediated rejection, most kidney graft allocation systems define unacceptable antigens to prevent transplantation in the presence of donor‐specific antibodies. Anti‐HLA‐C and anti‐HLA‐DP antibodies are often not included in these algorithms, including the French allocation system, despite growing evidence supporting ...
Margot Lepage, Thomas Barba, Xavier Charmetant, Luc Chauvelot, Manon Guezennec, Kevin Goret‐Roycourt, Fanny Buron, Olivier Thaunat, Emmanuel Morelon, Valérie Dubois, Alice Koenig   +10 more
wiley   +1 more source

Temporal Change in Blood Group after Bone Marrow Transplant: A Case of Successful ABO-Incompatible Deceased Donor Transplant

Case Reports in Transplantation, 2020
ABO-incompatible kidney transplantation has been successfully utilised in a deceased donor and living donor kidney transplantation to improve organ utilisation and decrease waiting times. We describe a case of a successful, unanticipated ABO-incompatible
Susanna Lam, Sebastian Hultin, John Preston, Scott Campbell   +3 more
doaj   +1 more source

Cumulative exposure to tacrolimus is associated with increased risk of malignancy for solid organ transplant recipients

International Journal of Cancer, Volume 158, Issue 12, Page 3152-3160, 15 June 2026.
What's new? Long‐term immunosuppression in solid organ transplant recipients (SOTRs) is linked to increased cancer risk. Although this risk potentially increases with greater immunosuppressant exposure, the exact dose‐response pattern remains uncertain.
Sergio A. Acuna, Xun Zhao, Maggie Jones‐Carr, Graham Smith, Kyla Naylor, Bima J. Hasjim, Shiyi Chen, An‐Wen Chan, Nancy Baxter, S. Joseph Kim, Mamatha Bhat   +10 more
wiley   +1 more source

ABO-Incompatible Kidney Transplantation : The Surprising Absence of Hyperacute Rejection [PDF]

Owing to the shortage of deceased donors in Japan, since 1989, we have performed ABO-incompatible kidney transplantation（ABO-IKTx） to expand the indication for living donor kidney transplantation.
Takahashi, Kota
core   +1 more source

ABO incompatible live donor renal transplant. Study of 48 patients after desensitization

Nefrología (English Edition), 2019
Background: Until recently, ABO-incompatible living donor kidney transplantation was regarded as an absolute contraindication. However, this kind of kidney transplantation has been used in the last years, with good results.
Constantino Fernández Rivera, María Calvo Rodríguez, Andrés López Muñíz, Tamara Ferreiro Hermida, Rocío Seijo Bestilleiro, Concepción Andón Saavedra, Andrea Galego García, Angel Alonso Hernández   +7 more
doaj   +1 more source

Porcine kidney xenotransplantation: From primate models to clinical reality

Animal Models and Experimental Medicine, Volume 9, Issue 6, Page 1142-1166, June 2026.
In the face of a critical shortage of human donor kidneys for end‐stage renal disease patients, porcine kidney xenotransplantation has emerged as a viable solution. This field has navigated major hurdles, including immune rejection, physiological incompatibilities, potential biomechanical differences and the risk of cross‐species infection. To overcome
Zihang Guo, Ling Zhang, Shoulong Deng, Chuan Qin   +3 more
wiley   +1 more source

Outcomes after ABO-incompatible heart transplantation in adults: A registry study.

, 2015
In the past, ABO incompatibility was considered an absolute contraindication to heart transplantation (HT) in adults. Advances in ABO-incompatible HT in pediatric patients and ABO-incompatible abdominal transplantation in adult patients have led to ...
Rådegran, Göran, Bergenfeldt, Henrik, Nilsson, Johan, Stehlik, Josef, Bućin, Dragan, Andersson, Bodil, Edwards, Leah, Nilsson, Johan,, Bergenfeldt, Henrik,, Andersson, Bodil,, Lund University., Rådegran, Göran,   +11 more
core   +1 more source

Impact of prophylactic cytomegalovirus immunoglobulin on cytomegalovirus viremia and graft function in ABO-incompatible living donor kidney transplantation: a retrospective analysis

Frontiers in Immunology
BackgroundCytomegalovirus (CMV) infection poses a significant risk to kidney transplant recipients. CMV immunoglobulin shows promising prophylactic effect, particularly in the context of ABO-incompatible transplants.
Linhong Zhong, Shijie Tang, Zhongping Pu, Kai Chen, Wenjia Di, Yifu Hou, Hongji Yang, Hongji Yang   +7 more
doaj   +1 more source

Abstracts

Molecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Flow cytometric measurement of ABO antibodies in ABO-incompatible living donor kidney transplantation.

, 2007
Due to different detection methods, a comparison of anti-A/B antibody (Ab) levels among transplantation centers after living donor ABO-incompatible kidney transplantation is problematic.
Weber M, Seebach JD, Cesar-Ozpamir M, Valli PV, Schanz U, Stussi G, Mueller RJ, Yung GP, Starke A, Fehr T, Wüthrich RP   +10 more
core   +1 more source